{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T14:20:50Z","timestamp":1700058050711},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Canc Educ"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1007\/bf03174368","type":"journal-article","created":{"date-parts":[[2010,2,9]],"date-time":"2010-02-09T21:34:03Z","timestamp":1265751243000},"source":"Crossref","is-referenced-by-count":6,"title":["Should menopausal women at increased risk for breast cancer use tamoxifen, raloxifene, or hormone therapy?: A framework for personalized risk assessment and counseling"],"prefix":"10.1007","volume":"22","author":[{"given":"Ellent T.","family":"Matloff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen M.","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Moyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nananda F.","family":"Col","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03174368_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/BF01807037","volume":"41","author":"M Daly","year":"1996","unstructured":"Daly M, Lerman C, Ross E, et al. Gail model breast cancer risk components are poor predictors of risk perception and screening behavior. Breast Cancer Res Treat. 1996;41:59\u201370.","journal-title":"Breast Cancer Res Treat"},{"key":"BF03174368_CR2","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z","volume":"77","author":"E Claus","year":"1996","unstructured":"Claus E, Schildkraut J, Thompson W, et al. The genetic attributable risks of breast and ovarian cancer. Cancer. 1996;77:2318\u20132324.","journal-title":"Cancer"},{"key":"BF03174368_CR3","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1056\/NEJM199705153362002","volume":"336","author":"F Couch","year":"1997","unstructured":"Couch F, DeShano M, Blackwood M, et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. New Engl J Med. 1997;336:1409\u20131415.","journal-title":"New Engl J Med"},{"key":"BF03174368_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1056\/NEJM199901143400201","volume":"340","author":"L Hartmann","year":"1999","unstructured":"Hartmann L, Schaid D, Woods J. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. New Engl J Med. 1999;340:77\u201384.","journal-title":"New Engl J Med"},{"key":"BF03174368_CR5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.7326\/0003-4819-133-11-200012050-00009","volume":"133","author":"K Kerlikowske","year":"2000","unstructured":"Kerlikowske K. Performance of screening mamography among women with and without a first degree relative with breast cancer. Ann Intern Med. 2000;133:855\u2013863.","journal-title":"Ann Intern Med"},{"key":"BF03174368_CR6","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1200\/JCO.1999.17.6.1939","volume":"17","author":"R Chlebowski","year":"1999","unstructured":"Chlebowski R, Collyar D, Somerfield M. American Society of Clinical Oncology technology assessment of breast cancer risk reduction strategies: Tamoxifen and raloxifene. J Clin Oncol. 1999;17:1939\u20131955.","journal-title":"J Clin Oncol"},{"key":"BF03174368_CR7","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"Fisher B, Constantino J, Wickerman D. Tamoxifen for the prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90:1371\u20131388.","journal-title":"J Natl Cancer Inst"},{"key":"BF03174368_CR8","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0140-6736(00)02677-5","volume":"356","author":"L. Bergman","year":"2003","unstructured":"Bergman L. Risk and prognosis of endometrial cancer after Tamoxifen for breast cancer. Lancet. 2003;356:881\u2013887.","journal-title":"Lancet"},{"key":"BF03174368_CR9","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/01.CIR.0000154545.84124.AC","volume":"111","author":"A Decensi","year":"2005","unstructured":"Decensi A. Effects of Tamoxifen on venous thromboembolic events in a breast cancer prevention trial. Circulation. 2005;111:650\u2013656.","journal-title":"Circulation"},{"key":"BF03174368_CR10","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/00001813-200409000-00003","volume":"15","author":"L Morales","year":"2004","unstructured":"Morales L. Acute effects of Tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients. Anticancer Drugs 2004;15:753\u2013760.","journal-title":"Anticancer Drugs"},{"key":"BF03174368_CR11","doi-asserted-by":"crossref","unstructured":"Vogel V, Constantino J, Wickerman D, et al. Effects of tamoxifen vs. raloxifene on the risk of developing invasive breast cancer and other disease outcomes; the NSABP study of tamoxifen and raloxifene (STAR) P-2 Trial. JAMA. 2006;295(23).","DOI":"10.1001\/jama.295.23.joc60074"},{"key":"BF03174368_CR12","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1200\/JCO.2005.11.027","volume":"23","author":"J Cuzick","year":"2005","unstructured":"Cuzick J. Aromatase inhibitors for breast cancer prevention. J Clin Oncol. 2005;23:1636\u20131643.","journal-title":"J Clin Oncol"},{"key":"BF03174368_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3810\/pgm.2000.07.1159","volume":"108","author":"D Morrissey","year":"2000","unstructured":"Morrissey D, Kirchner J. Management of the climacteric. Options abound to relieve women\u2019s midlife symptoms. Postgrad Med. 2000;108:85\u2013100.","journal-title":"Postgrad Med"},{"key":"BF03174368_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"Women\u2019s Health Initiative (WHI)","year":"2002","unstructured":"Women\u2019s Health Initiative (WHI). Risks and benefits of estrogen plus progestin in healthy postmenopausal women, principal results from the Women\u2019s Health Initiative Randomized Controlled Trial. JAMA. 2002;288:321\u2013333.","journal-title":"JAMA"},{"key":"BF03174368_CR15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/0003-4819-140-3-200402030-00009","volume":"140","author":"J Haas","year":"2004","unstructured":"Haas J, Kaplan C, Gerstenberger E, et al. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med. 2004;140:184\u2013188.","journal-title":"Ann Intern Med"},{"key":"BF03174368_CR16","volume-title":"Cancer: Principles and Practice of Oncology","author":"E Matloff","year":"2005","unstructured":"Matloff E. Genetic counseling. In DeVita V, Hellman S, Rosenberg S (eds.). Cancer: Principles and Practice of Oncology. 7th Ed. Philadelphia: Lippincott-Raven; 2005.","edition":"7th Ed"},{"key":"BF03174368_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S1049-3867(02)00139-1","volume":"12","author":"S Schoelle","year":"2002","unstructured":"Schoelle S, Chang J, Harman J, et al. Trends in women\u2019s health services by type of physician seen: data from the 1985 and 1997\u201398 NAMCS. Womens Health Issues. 2002;12:165\u2013177.","journal-title":"Womens Health Issues"},{"key":"BF03174368_CR18","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1177\/0884217503257339","volume":"32","author":"R Theroux","year":"2003","unstructured":"Theroux R, Taylor K. Women\u2019s decision making about the use of hormonal and nonhormonal remedies for the menopausal transition. J Obstet Gynecol Neonatal Nurs. 2003;32:712\u2013723.","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"BF03174368_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3122\/jabfm.19.2.122","volume":"19","author":"M Burg","year":"2006","unstructured":"Burg M, Fraser K, Gui S, et al. Treatment of menopausal symptoms in family medicine settings following the Women\u2019s Health Initiative findings. J Am Board Fam Med. 2006;19:122\u2013131.","journal-title":"J Am Board Fam Med"},{"issue":"7","key":"BF03174368_CR20","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1089\/jwh.2006.15.843","volume":"15","author":"E Matloff","year":"2006","unstructured":"Matloff E, Moyer A, Shannon K, et al. Healthy women with a family history of breast cancer: Impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision-making. J Womens Health. 2006;15(7):843\u2013856.","journal-title":"J Womens Health"},{"key":"BF03174368_CR21","unstructured":"Santen R, Borwhat M, Gleason S. Menopause: What Every Woman Should Know. The Endocrine Society; 1997."},{"key":"BF03174368_CR22","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1001\/jama.277.14.1140","volume":"277","author":"N Col","year":"1997","unstructured":"Col N, Eckman M, Karas R, et al. Patient-specific decisions about hormone replacement therapy in postmenopausal women. JAMA. 1997;277:1140\u20131147.","journal-title":"JAMA"},{"key":"BF03174368_CR23","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1001\/archinte.159.13.1458","volume":"159","author":"N Col","year":"1999","unstructured":"Col N, Pauker S, Goldberg R, et al. Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women. Arch Intern Med. 1999;159:1458\u20131466.","journal-title":"Arch Intern Med"},{"key":"BF03174368_CR24","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1001\/archinte.164.15.1634","volume":"164","author":"N Col","year":"2004","unstructured":"Col N, Weber G, Stiggelbout A, et al. Short-term menopausal hormone therapy for symptom relief: an updated decision model. Arch Intern Med. 2004;164:1634\u20131640.","journal-title":"Arch Intern Med"},{"key":"BF03174368_CR25","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1001\/jama.291.19.2359","volume":"291","author":"R Epstein","year":"2004","unstructured":"Epstein R, Alper B, Quill T. Communicating evidence for participatory decision making. JAMA. 2004;291:2359\u20132366.","journal-title":"JAMA"},{"key":"BF03174368_CR26","first-page":"292","volume":"26","author":"H Sampson","year":"2002","unstructured":"Sampson H. Alcohol and other factors affecting osteoporosis risk in women. Alcohol Res Health. 2002;26:292\u2013298.","journal-title":"Alcohol Res Health"},{"key":"BF03174368_CR27","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S1470-2045(02)00875-6","volume":"3","author":"A Clamp","year":"2002","unstructured":"Clamp A, Danson S, Clemons M. Hormonal risk factors for breast cancer: identification, chemoprevention, and other intervention strategies. Lancet Oncol. 2002;3:611\u2013619.","journal-title":"Lancet Oncol"},{"key":"BF03174368_CR28","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/jama.290.4.465","volume":"290","author":"L Travis","year":"2003","unstructured":"Travis L, Hill D, Dores G. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA. 2003;290:465\u2013475.","journal-title":"JAMA"},{"key":"BF03174368_CR29","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","volume":"291","author":"Women\u2019s Health Initiative (WHI)","year":"2004","unstructured":"Women\u2019s Health Initiative (WHI). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women\u2019s Health Initiative radomized controlled trial. JAMA. 2004;291:1701\u20131712.","journal-title":"JAMA"},{"key":"BF03174368_CR30","first-page":"1038","volume":"117","author":"American College of Physicians (ACP)","year":"1999","unstructured":"American College of Physicians (ACP). Guidelines for counseling postmenopausal women about preventative hormone therapy. Ann Intern Med. 1999;117:1038\u20131041.","journal-title":"Ann Intern Med"},{"key":"BF03174368_CR31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7326\/0003-4819-131-4-199908170-00005","volume":"131","author":"M Connelly","year":"1999","unstructured":"Connelly M, Ferrari N, Hagen N. Patient-identified needs for hormone replacement therapy counseling: A qualitative study. Ann Intern Med. 1999;131:265\u2013268.","journal-title":"Ann Intern Med"},{"key":"BF03174368_CR32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/ajmg.10010","volume":"106","author":"K Greendale","year":"2001","unstructured":"Greendale K, Pyeritz R. Empowering primary care health professionals in medical genetics: how soon? how fast? how far? Am J Med Genet. 2001;106:223\u2013232.","journal-title":"Am J Med Genet"},{"key":"BF03174368_CR33","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/fampra\/16.5.468","volume":"16","author":"A Fry","year":"1999","unstructured":"Fry A, Campbell H, Gudmundsdottir H, et al. GP\u2019s views on their role in cancer genetics services and current practice. Fam Pract. 1999;16:468\u2013474.","journal-title":"Fam Pract"},{"key":"BF03174368_CR34","doi-asserted-by":"crossref","unstructured":"Wilkins-Haug L, Erickson K, Hill L, et al. Obstetrician-Gynecologist\u2019s opinions and attitudes on the role of genetics in women\u2019s health. J Women Health Gen-B. 2000;9(8).","DOI":"10.1089\/152460900750020900"}],"container-title":["Journal of Cancer Education"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03174368.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF03174368\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03174368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03174368.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T13:58:35Z","timestamp":1652795915000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF03174368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["BF03174368"],"URL":"https:\/\/doi.org\/10.1007\/bf03174368","relation":{},"ISSN":["0885-8195","1543-0154"],"issn-type":[{"value":"0885-8195","type":"print"},{"value":"1543-0154","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]},"article-number":"10"}}